Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01317329 · ClinicalTrials.gov registry record · NA
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
A NA study of Obesity and Hypertension, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT01317329: Completed NA study of Obesity and Hypertension, sponsored by University of Wisconsin, Madison.
NCT01317329 is a NA study of Obesity and Hypertension that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 90 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01317329, a NA study of Obesity and Hypertension, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.
Primary Outcome
Ultrasound based brachial artery reactivity tests will be performed at entry before CPAP therapy and at 4, 12 weeks post CPAP use and 5-7 days after CPAP withdrawal
Conditions Studied
Interventions
- OTHER Clinically prescribed CPAP therapy
Study Locations (1)
Wisconsin
- Wisconsin Sleep - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01317329 record still lists
NCT01317329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower).
The record links to 10 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Clinically prescribed CPAP therapy is the first listed.
NCT01317329 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01317329 about?
NCT01317329 is a clinical study titled ""Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"". The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.
What is the current status of trial NCT01317329?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-03. Estimated completion is 2014-12.
What conditions does trial NCT01317329 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Sleep Apnea, Obstructive, Hypoxia, Sleep Disorders.
What interventions are being tested in trial NCT01317329?
The interventions under investigation include: Clinically prescribed CPAP therapy (OTHER).
Who is sponsoring clinical trial NCT01317329?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01317329 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01317329's enrollment target sits among peer trials
90 520th of 1053 higher than 526 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia